Track topics on Twitter Track topics that are important to you
Seed funding is available for up to 10 early stage businesses/commercialisation projects for a maximum of 12 months to carry out proof of concept research.Key benefits include a programme of business workshops, one-to-one coaching, mentoring support and access to clinicians/clinical validation and industry leaders in your field. Advice and introductions to secure follow-on funding will also be provided.The Accelerator Partners include Manchester Science Partnerships, BioCity, Alderley Park Ventures, Catapult Ventures, the Northern Health Service Alliance (NHSA) and the N8 Research Partnership.Applications are invited from entrepreneurs, including students, post-docs and academics at any career stage from anywhere in the UK, but key project activities must be led from Alderley Park. Research must be in the field of life sciences and healthcare and can include therapeutics, diagnostics, devices and digital media. Inter-disciplinary projects are encouraged.For more information and a copy of the business proposal template for all applications, please contact firstname.lastname@example.org (www.biocity.co.uk/accelerator).NEXT ARTICLE
Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.
Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...